Treat and extend versus pro re nata regimens of ranibizumab and aflibercept in neovascular age-related macular degeneration: a comparative study

Treat and Extend versusPro Re Nataregimens of ranibizumab in neovascular age-related macular degeneration: a comparative 12 Month study

(2016) Katja Hatz et al.   ACTA OPHTHALMOLOGICA

Five-Year Outcomes with Anti–Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration

(2016) Maureen G. Maguire et al.   OPHTHALMOLOGY

Comparison of Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration According to LUCAS Treat-and-Extend Protocol

(2015) Karina Berg et al.   OPHTHALMOLOGY

Recent developments in the treatment of age-related macular degeneration

(2014) Frank G. Holz et al.   JOURNAL OF CLINICAL INVESTIGATION

A 12-MONTH PROSPECTIVE TRIAL OF INJECT AND EXTEND REGIMEN FOR RANIBIZUMAB TREATMENT OF AGE-RELATED MACULAR DEGENERATION

(2013) Nicholas Toalster et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration

(2012) Jeffrey S. Heier et al.   OPHTHALMOLOGY

Bevacizumab for Neovascular Age-Related Macular Degeneration Using a Treat-and-Extend Regimen: Clinical and Economic Impact

(2011) Gary Shienbaum et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

A systematic review of the efficacy and safety outcomes of anti-VEGF agents used for treating neovascular age-related macular degeneration: comparison of ranibizumab and bevacizumab

(2011) Paul Mitchell   CURRENT MEDICAL RESEARCH AND OPINION

Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration

(2011)   NEW ENGLAND JOURNAL OF MEDICINE

A Treat and Extend Regimen Using Ranibizumab for Neovascular Age-Related Macular DegenerationClinical and Economic Impact

(2010) Omesh P. Gupta et al.   OPHTHALMOLOGY

INJECT AND EXTEND DOSING VERSUS DOSING AS NEEDED

(2010) Hassiba Oubraham et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year 2 of the PrONTO Study

(2009) Geeta A. Lalwani et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Endophthalmitis Associated with Intravitreal Anti-Vascular Endothelial Growth Factor Therapy Injections in An Office Setting

(2008) Suman Pilli et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY